BCM
SBBP

Bayesian Capital Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bayesian Capital Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-22,700
Closed -$102K – 821
2018
Q4 		$102K Buy
22,700
+9,200
+68% +$44.9K 0.02% 554
2018
Q3 		$65K Buy
+13,500
New +$69.1K 0.01% 598

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Bayesian Capital Management's SBBP Position: Q1 2019 in Review

Bayesian Capital Management sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2019, closing a stake of 22,700 shares — an estimated $102K sold.

Bayesian Capital Management first reported a position in SBBP in Q3 2018 and held it in 2 quarters. The position peaked at $102K in Q4 2018. 51 funds tracked by Wall St. Rank hold SBBP as of Q1 2019.

  • Bayesian Capital Management reported no remaining Strongbridge Biopharma plc. position as of Q1 2019 after selling out during the quarter.
  • Bayesian Capital Management sold 22,700 Strongbridge Biopharma plc. shares in Q1 2019, an estimated $102K.
  • Bayesian Capital Management first reported a position in Strongbridge Biopharma plc. in Q3 2018 and held it in 2 quarters.
  • Bayesian Capital Management's Strongbridge Biopharma plc. position peaked at $102K in Q4 2018.
  • 51 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2019.

Based on Bayesian Capital Management's 13F filing for Q1 2019, filed 14 May 2019.